Ligand validation:4CAF

370: 4-[(2-{5-[(3,5-dimethyl-1H-pyrazol-4-yl)methyl]-1,3,4-oxadiazol-2-yl}-1-benzothiophen-3-yl)oxy]piperidine

370 is a Ligand Of Interest in 4CAF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CAF_370_B_1411	95%	13%	0.07	0.976	2.11	1.84	5	5	0	0	100%	1
4CAF_370_A_1411	94%	10%	0.074	0.972	2.57	1.82	6	5	0	0	100%	1
4CAF_370_C_1411	74%	8%	0.107	0.937	3.01	1.65	8	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.